셀 기반 어세이 시장 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2032년)

The global demand for Cell Based Assays Market is presumed to reach the market size of nearly USD 38.14 Billion by 2032 from USD 20.94 Billion in 2023 with a CAGR of 6.89% under the study period 2024 - 2032.

Cell-based assays are experimental techniques for studying cellular processes, interactions, and responses to external stimuli or compounds. They involve culturing cells in vitro and measuring specific cellular functions, such as proliferation, viability, apoptosis, migration, differentiation, or gene expression. These assays are widely used in basic research, drug discovery, toxicity testing, and drug screening to investigate disease mechanisms, evaluate drug efficacy and safety, and identify potential therapeutic targets or compounds.

MARKET DYNAMICS

The escalating demand for drug discovery and development tools that can accurately predict drug efficacy, toxicity, and safety profiles drives the adoption of cell-based assays as valuable tools in pharmaceutical and biotechnology research. These assays offer physiological relevance and biological complexity, enabling the assessment of drug candidates' effects on cellular processes, signaling pathways, and disease mechanisms in a more clinically relevant context. Additionally, cell culture techniques, automation, imaging technologies, and high-content analysis advancements have improved cell-based assays' scalability, throughput, and reproducibility, making them indispensable in drug screening, toxicity testing, and personalized medicine applications.

Furthermore, the spurring prevalence of chronic diseases, such as cancer, cardiovascular disorders, and neurological conditions, has spurred the demand for cell-based assays for disease modeling, target validation, and biomarker discovery, driving market expansion. Moreover, regulatory agencies' increasing emphasis on safety and efficacy assessments in drug development, coupled with the adoption of 3D cell culture models and organ-on-a-chip technologies, is fueling the innovation and adoption of advanced cell-based assay platforms. Collaborations between pharmaceutical companies, contract research organizations (CROs), and academic institutions to develop and validate cell-based assay platforms drive market growth. Furthermore, the increasing investment in precision medicine and personalized therapeutics creates opportunities for cell-based assays in patient stratification and treatment optimization. However, increasing competition from alternative assay technologies and concerns about reproducibility and reliability may challenge the market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of cell based assays. The growth and trends of cell based assays industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the cell based assays market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product Type

• Instruments
• Assay Kits
• Reagents & Consumables
• Software
• Services

By Application

• Drug Discovery
• Basic Research
• Predictive Toxicology
• Others

By End-User

• Pharmaceutical & Biotech Companies
• Academic Institutions
• Contract Research Organizations
• Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Cell Based Assays market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Cell Based Assays market include Danaher Corporation, GE Healthcare Inc., Charles River Laboratories, Lonza Group Ltd., Thermo Fisher Scientific Inc., Merck & Co., PerkinElmer Inc., Cell Signaling Technology, Inc., Becton, Dickinson and Company, Promega Corporation. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. CELL BASED ASSAYS - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product Type
  • 3.7.2 Market Attractiveness Analysis By Application
  • 3.7.3 Market Attractiveness Analysis By End-user
  • 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL CELL BASED ASSAYS MARKET ANALYSIS BY PRODUCT TYPE

• 5.1. Overview By Product Type
• 5.2. Historical and Forecast Data
• 5.3. Analysis By Product Type
• 5.4. Instruments Historic and Forecast Sales By Regions
• 5.5. Assay Kits Historic and Forecast Sales By Regions
• 5.6. Reagents & Consumables Historic and Forecast Sales By Regions
• 5.7. Software Historic and Forecast Sales By Regions
• 5.8. Services Historic and Forecast Sales By Regions

6. GLOBAL CELL BASED ASSAYS MARKET ANALYSIS BY APPLICATION

• 6.1. Overview By Application
• 6.2. Historical and Forecast Data
• 6.3. Analysis By Application
• 6.4. Drug Discovery Historic and Forecast Sales By Regions
• 6.5. Basic Research Historic and Forecast Sales By Regions
• 6.6. Predictive Toxicology Historic and Forecast Sales By Regions
• 6.7. Others Historic and Forecast Sales By Regions

7. GLOBAL CELL BASED ASSAYS MARKET ANALYSIS BY END-USER

• 7.1. Overview By End-user
• 7.2. Historical and Forecast Data
• 7.3. Analysis By End-user
• 7.4. Pharmaceutical & Biotech Companies Historic and Forecast Sales By Regions
• 7.5. Academic Institutions Historic and Forecast Sales By Regions
• 7.6. Contract Research Organizations Historic and Forecast Sales By Regions
• 7.7. Others Historic and Forecast Sales By Regions

8. GLOBAL CELL BASED ASSAYS MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.3.2 North America By Segment Sales Analysis
  • 8.3.3 North America By Country Sales Analysis
  • 8.3.4 United States Sales Analysis
  • 8.3.5 Canada Sales Analysis
  • 8.3.6 Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.4.2 Europe By Segment Sales Analysis
  • 8.4.3 Europe By Country Sales Analysis
  • 8.4.4 United Kingdom Sales Analysis
  • 8.4.5 France Sales Analysis
  • 8.4.6 Germany Sales Analysis
  • 8.4.7 Italy Sales Analysis
  • 8.4.8 Russia Sales Analysis
  • 8.4.9 Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.5.2 Asia Pacific By Segment Sales Analysis
  • 8.5.3 Asia Pacific By Country Sales Analysis
  • 8.5.4 China Sales Analysis
  • 8.5.5 India Sales Analysis
  • 8.5.6 Japan Sales Analysis
  • 8.5.7 South Korea Sales Analysis
  • 8.5.8 Australia Sales Analysis
  • 8.5.9 South East Asia Sales Analysis
  • 8.5.10 Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.6.2 Latin America By Segment Sales Analysis
  • 8.6.3 Latin America By Country Sales Analysis
  • 8.6.4 Brazil Sales Analysis
  • 8.6.5 Argentina Sales Analysis
  • 8.6.6 Peru Sales Analysis
  • 8.6.7 Chile Sales Analysis
  • 8.6.8 Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 8.7.2 Middle East & Africa By Segment Sales Analysis
  • 8.7.3 Middle East & Africa By Country Sales Analysis
  • 8.7.4 Saudi Arabia Sales Analysis
  • 8.7.5 UAE Sales Analysis
  • 8.7.6 Israel Sales Analysis
  • 8.7.7 South Africa Sales Analysis
  • 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE CELL BASED ASSAYS COMPANIES

• 9.1. Cell Based Assays Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10. COMPANY PROFILES OF CELL BASED ASSAYS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Market Concentration Rate
• 10.3. Danaher Corporation
  • 10.3.1 Company Overview
  • 10.3.2 Company Revenue
  • 10.3.3 Products
  • 10.3.4 Recent Developments
• 10.4. GE Healthcare Inc.
  • 10.4.1 Company Overview
  • 10.4.2 Company Revenue
  • 10.4.3 Products
  • 10.4.4 Recent Developments
• 10.5. Charles River Laboratories
  • 10.5.1 Company Overview
  • 10.5.2 Company Revenue
  • 10.5.3 Products
  • 10.5.4 Recent Developments
• 10.6. Lonza Group Ltd.
  • 10.6.1 Company Overview
  • 10.6.2 Company Revenue
  • 10.6.3 Products
  • 10.6.4 Recent Developments
• 10.7. Thermo Fisher Scientific Inc.
  • 10.7.1 Company Overview
  • 10.7.2 Company Revenue
  • 10.7.3 Products
  • 10.7.4 Recent Developments
• 10.8. Merck & Co.
  • 10.8.1 Company Overview
  • 10.8.2 Company Revenue
  • 10.8.3 Products
  • 10.8.4 Recent Developments
• 10.9. PerkinElmer Inc.
  • 10.9.1 Company Overview
  • 10.9.2 Company Revenue
  • 10.9.3 Products
  • 10.9.4 Recent Developments
• 10.10. Cell Signaling Technology Inc.
  • 10.10.1 Company Overview
  • 10.10.2 Company Revenue
  • 10.10.3 Products
  • 10.10.4 Recent Developments
• 10.11. Becton
  • 10.11.1 Company Overview
  • 10.11.2 Company Revenue
  • 10.11.3 Products
  • 10.11.4 Recent Developments
• 10.12. Dickinson And Company
  • 10.12.1 Company Overview
  • 10.12.2 Company Revenue
  • 10.12.3 Products
  • 10.12.4 Recent Developments
• 10.13. Promega Corporation
  • 10.13.1 Company Overview
  • 10.13.2 Company Revenue
  • 10.13.3 Products
  • 10.13.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies